Literature DB >> 33627440

Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases.

Victoria Furer1,2, Christien Rondaan3, Nancy Agmon-Levin2,4, Sander van Assen5, Marc Bijl6, Meliha Crnkic Kapetanovic7, Annette de Thurah8,9, Ulf Mueller-Ladner10, Daphna Paran11,2, Karen Schreiber12,13, Klaus Warnatz14, Nico M Wulffraat15, Ori Elkayam11,2.   

Abstract

In view of the COVID-19 pandemic, there is an unmet clinical need for the guidelines on vaccination of patients with autoimmune inflammatory rheumatic diseases (AIIRD). This position paper summarises the current data on COVID-19 infection in patients with AIIRD and development of vaccines against COVID-19, discusses the aspects of efficacy and safety of vaccination, and proposes preliminary considerations on vaccination against COVID-19 in patients with AIIRD, mainly based on the expert opinion and knowledge on the use of other vaccines in this population of patients. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  COVID-19; autoimmune diseases; vaccination

Year:  2021        PMID： 33627440     DOI： 10.1136/rmdopen-2021-001594

Source DB:  PubMed          Journal:  RMD Open        ISSN： 2056-5933


  21 in total

1.  COVID-19 vaccine hesitancy among Mexican outpatients with rheumatic diseases.

Authors:  Guillermo Guaracha-Basáñez; Irazú Contreras-Yáñez; Everardo Álvarez-Hernández; Carla Marina Román-Montes; Graciela Meza-López Y Olguín; María José Morales-Graciano; Salvador Saúl Valverde-Hernández; Ingris Peláez-Ballestas; Virginia Pascual-Ramos
Journal:  Hum Vaccin Immunother       Date:  2021-12-02       Impact factor: 3.452

2.  Immunogenicity 6 months post COVID-19 mRNA-vaccination among adolescents with juvenile idiopathic arthritis on treatment with TNF-inhibitors.

Authors:  Dimitra Dimopoulou; Maria N Tsolia; Nikos Spyridis; Despoina N Maritsi
Journal:  Rheumatology (Oxford)       Date:  2022-07-05       Impact factor: 7.046

3.  Safety and tolerability of the COVID-19 messenger RNA vaccine in adolescents with juvenile idiopathic arthritis treated with tumor necrosis factor inhibitors.

Authors:  Dimitra Dimopoulou; Nikos Spyridis; George Vartzelis; Maria N Tsolia; Despoina N Maritsi
Journal:  Arthritis Rheumatol       Date:  2022-01-04       Impact factor: 15.483

4.  Correlation between BNT162b2 mRNA Covid-19 vaccine-associated hypermetabolic lymphadenopathy and humoral immunity in patients with hematologic malignancy.

Authors:  Dan Cohen; Shir Hazut Krauthammer; Yael C Cohen; Chava Perry; Irit Avivi; Yair Herishanu; Einat Even-Sapir
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-05-08       Impact factor: 9.236

5.  Immunogenicity of Inactivated SARS-CoV-2 Vaccines in Patients With Rheumatoid Arthritis: A Case Series.

Authors:  Ting Zhao; Jiayan Shen; Youyang Zhu; Xiaofang Tian; Guangfen Wen; Yuanyuan Wei; Bonan Xu; Chenyang Fu; Zhaohu Xie; Yujiang Xi; Zhenmin Li; Jiangyun Peng; Yang Wu; Xiaohu Tang; Chunping Wan; Lei Pan; Zhaofu Li; Dongdong Qin
Journal:  Front Public Health       Date:  2022-04-25

6.  Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies.

Authors:  Laura Boekel; Maurice Steenhuis; Femke Hooijberg; Yaëlle R Besten; Zoé L E van Kempen; Laura Y Kummer; Koos P J van Dam; Eileen W Stalman; Erik H Vogelzang; Olvi Cristianawati; Sofie Keijzer; Gestur Vidarsson; Alexandre E Voskuyl; Luuk Wieske; Filip Eftimov; Ronald van Vollenhoven; Taco W Kuijpers; S Marieke van Ham; Sander W Tas; Joep Killestein; Maarten Boers; Michael T Nurmohamed; Theo Rispens; Gertjan Wolbink
Journal:  Lancet Rheumatol       Date:  2021-08-06

7.  Severity and mortality of COVID-19 in patients with systemic sclerosis: a Brazilian multicenter study.

Authors:  Sandra Maximiano de Oliveira; Lucas Victória de Oliveira Martins; Ana Paula Lupino-Assad; Ana Cristina Medeiros-Ribeiro; Daniela Aparecida de Moraes; Ana Paula Toledo Del-Rio; Maria Carolina Oliveira; Percival Degrava Sampaio-Barros; Cristiane Kayser
Journal:  Semin Arthritis Rheum       Date:  2022-02-25       Impact factor: 5.431

8.  Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine.

Authors:  Dennis Niebel; Veronika Ralser-Isselstein; Kristel Jaschke; Christine Braegelmann; Thomas Bieber; Joerg Wenzel
Journal:  Dermatol Ther       Date:  2021-06-08       Impact factor: 3.858

9.  Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt.

Authors:  Nevin Hammam; Samar Tharwat; Rawhya R El Shereef; Ahmed M Elsaman; Noha M Khalil; Hanan M Fathi; Mohamed N Salem; Hanan M El-Saadany; Nermeen Samy; Amany S El-Bahnasawy; Yousra H Abdel-Fattah; Marwa A Amer; Emad ElShebini; Amira T El-Shanawany; Dina H El-Hammady; Rasha Abdel Noor; Marwa ElKhalifa; Faten Ismail; Rasha M Fawzy; Amany R El-Najjar; Zahraa I Selim; Nouran M Abaza; Ahmed R Radwan; Mervat IAbd Elazeem; Wael Abdel Mohsen; Abdel Hafeez Moshrif; Eman F Mohamed; Loay I Aglan; Soha Senara; Maha E Ibrahim; Iman Khalifa; Rasha El Owaidy; Noha El Fakharany; Reem Hamdy A Mohammed; Tamer A Gheita
Journal:  Rheumatol Int       Date:  2021-07-09       Impact factor: 2.631

Review 10.  [Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV‑2/COVID‑19 pandemic, including recommendations for COVID‑19 vaccination].

Authors:  Christof Specker; Peer Aries; Jürgen Braun; Gerd Burmester; Rebecca Fischer-Betz; Rebecca Hasseli; Julia Holle; Bimba Franziska Hoyer; Christof Iking-Konert; Andreas Krause; Klaus Krüger; Martin Krusche; Jan Leipe; Hanns-Martin Lorenz; Frank Moosig; Rotraud Schmale-Grede; Matthias Schneider; Anja Strangfeld; Reinhard Voll; Anna Voormann; Ulf Wagner; Hendrik Schulze-Koops
Journal:  Z Rheumatol       Date:  2021-08       Impact factor: 1.372
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.